Symbol
Dianthus Therapeutics, Inc.
Full name of the company.
MEDICAL-BIOMED/GENETICS
Industry name
DRUGS
Major industry name
Medical
Sector name
$16.97
Current price of the stock
$483K
Trading volume of the stock
$581.0M
Market capitalization of the company
Small Cap
Category of market capitalization
-
Long-term growth mean estimate
4.92
Mean analyst rating
209.96%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
18.30
Current ratio
100.00%
Gross profit margin
-1376.61%
Operating profit margin
-1376.61%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-1159.02%
Pretax profit margin
-1159.02%
Net profit margin
-7.45%
Measures profitability relative to shareholders' equity
-7.45%
ROE excluding intangible assets
-7.11%
Measures profitability relative to total assets
-7.45%
Measures profitability relative to invested capital
0.01
Asset turnover ratio
-
Inventory turnover ratio
0.81
Receivables turnover ratio
111.17
Average number of days it takes to collect receivables
1.18
Measures valuation relative to earnings
-
P/E based on future earnings estimates
108.27
Measures valuation relative to sales
1.47
Measures valuation relative to book value
-1.68
Measures valuation relative to operating cash flow
-1.68
Measures valuation relative to free cash flow
0
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
